Reinventing depression treatment via transcranial magnetic brain stimulation (TMS)
Conclusions: SAINT, an accelerated, high-dose, iTBS protocol with fcMRI-guided targeting, was well tolerated and safe. Double-blinded sham-controlled trials are needed to confirm the remission rate observed in this initial study.
The Study in Context:
Machine-learning study finds EEG brain signatures that predict response to antidepressant treatments
Should Cognitive Behavioural Therapy (not antidepressant drugs) be the first-line treatment for depression?
Neuroengineering meets neuroethics to address treatment-resistant depression
CVS Health: Cognitive behavioral therapy (CBT) apps may help you more than sleeping pills
A call to action: We need the right incentives to guide ethical innovation in neurotech and healthcare
New report: Empowering 8 Billion Minds via Ethical Development and Adoption of Neurotechnologies
10 highlights from the 2019 SharpBrains Virtual Summit
?
Rethinking and Retooling Brain Health and Mental Health from SharpBrains
Source: SharpBrains - Category: Neuroscience Authors: SharpBrains Tags: Cognitive Neuroscience Health & Wellness Technology antidepressant treatments brain stimulation cognitive side effects depression magnetic brain stimulation neurological disorders noninvasive brain stimulation noninvasive neurotechnolo Source Type: blogs
More News: Behavioural Therapy | Brain | Clinical Trials | Cognitive Behavior Therapy | Depression | Learning | Medical Ethics | Men | Neurology | Neuroscience | Psychiatry | Study | Universities & Medical Training